Fib(420), the novel fibrinogen subclass: Newborn levels are higher than adult

被引:35
作者
Grieninger, G
Lu, XH
Cao, Y
Fu, YP
Kudryk, BJ
Galanakis, DK
Hertzberg, KM
机构
[1] NEW YORK BLOOD CTR, LINDSLEY F KIMBALL RES INST, NEW YORK, NY 10021 USA
[2] SUNY STONY BROOK, DEPT PATHOL, STONY BROOK, NY 11794 USA
关键词
D O I
10.1182/blood.V90.7.2609.2609_2609_2614
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Fib(420) is a recently identified subclass of normal human fibrinogen in which two extended alpha chain isoforms (alpha(E)) replace the common a chains, yielding a molecule (ca. 420 kD) which is larger than the more abundant 340-kD form. Evidence for preservation of this subclass throughout vertebrate evolution suggests it performs some as yet unidentified vital function. A survey was undertaken to establish the range of plasma Fib(420) levels in normal, healthy adults and in placental cord (fetal) blood. For measuring Fib(420), a quantitative Western blot assay was developed using monoclonal antibody against the exon-VI encoded C-terminus of the molecule's unique alpha(E) chain. This alpha(E) chain signal was normalized to that of the beta chain, common to both fibrinogen forms. Analysis of plasma samples from the adult and newborn cohorts in = 25 each; total fibrinogen ca. 2.6 mg/mL in both) revealed a statistically significant difference, with a mean level of 100 +/- 28 mu g/mL in the neonate compared to 34 +/- 7 mu g/mL in the adult. On average, 1 out of every 100 fibrinogen molecules in adult plasma belongs to the Fib(420) subclass. Unlike in the newborn, adult Fib(420) levels remained the same over a wide range of total plasma fibrinogen. The striking difference observed between these two cohorts suggests a changing developmental expression of the Fib(420) subclass and a homeostatic control operating in later stages of life. (C) 1997 by The American Society of Hematology.
引用
收藏
页码:2609 / 2614
页数:6
相关论文
共 18 条
[1]
DEVELOPMENT OF THE HUMAN COAGULATION SYSTEM IN THE FULL-TERM INFANT [J].
ANDREW, M ;
PAES, B ;
MILNER, R ;
JOHNSTON, M ;
MITCHELL, L ;
TOLLEFSEN, DM ;
POWERS, P .
BLOOD, 1987, 70 (01) :165-172
[2]
ANDREW M, 1990, AM J PEDIAT HEMATOL, V12, P95
[3]
CARBOXY-TERMINAL-EXTENDED VARIANT OF THE HUMAN FIBRINOGEN ALPHA-SUBUNIT - A NOVEL EXON CONFERRING MARKED HOMOLOGY TO BETA-SUBUNIT AND GAMMA-SUBUNIT [J].
FU, YP ;
WEISSBACH, L ;
PLANT, PW ;
ODDOUX, C ;
CAO, Y ;
LIANG, TJ ;
ROY, SN ;
REDMAN, CM ;
GRIENINGER, G .
BIOCHEMISTRY, 1992, 31 (48) :11968-11972
[4]
FIB(420) - A NORMAL HUMAN VARIANT OF FIBRINOGEN WITH 2 EXTENDED ALPHA-CHAINS [J].
FU, YP ;
GRIENINGER, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (07) :2625-2628
[5]
FIBRINOGEN ALPHA-GENES - CONSERVATION OF BIPARTITE TRANSCRIPTS AND CARBOXY-TERMINAL-EXTENDED ALPHA-SUBUNITS IN VERTEBRATES [J].
FU, YP ;
CAO, Y ;
HERTZBERG, KM ;
GRIENINGER, G .
GENOMICS, 1995, 30 (01) :71-76
[6]
GRIENINGER G, 1979, ANN CLIN LAB SCI, V9, P511
[7]
REEVALUATION OF SOME PROPERTIES OF FIBRINOGEN, PURIFIED FROM CORD BLOOD OF NORMAL NEWBORNS [J].
HAMULYAK, K ;
NIEUWENHUIZEN, W ;
DEVILEE, PP ;
HEMKER, HC .
THROMBOSIS RESEARCH, 1983, 32 (03) :301-310
[8]
KUDRYK BJ, 1989, MONOCLONAL ANTIBODIE, P365
[9]
CLEAVAGE OF STRUCTURAL PROTEINS DURING ASSEMBLY OF HEAD OF BACTERIOPHAGE-T4 [J].
LAEMMLI, UK .
NATURE, 1970, 227 (5259) :680-+
[10]
MACKIEWICZ A, 1995, ANN NY ACAD SCI, V762, P1